© 2021 MJH Life Sciences and HCPLive - Clinical news for connected physicians. All rights reserved.
© 2021 MJH Life Sciences™ and HCPLive - Clinical news for connected physicians. All rights reserved.
January 12, 2021
The current literature points to the potential efficacy and safety of the anti-depressant drug, but more research is needed to verify its role in managing pain caused by vaso-occlusive crises.
January 11, 2021
Dr. Rakesh Jetly is leading a new phase 2 study testing psychedelics in veterans with PTSD.
January 08, 2021
Adolescent delinquency and perceived classmate drug use were linked to adolescent opioid misuse.
January 07, 2021
In nearly 1.9 million doses of the COVID-19 vaccine there has been only 21 total cases of anaphylaxis.
December 22, 2020
The 5 companies issued letters will have 15 days to submit a compliance plan.
November 25, 2020
Dr. Tobias Moeller-Bertram discusses how alternative therapies could replace opioids in the future for chronic pain.
November 22, 2020
An interview with a pain specialist on advancing alternative pain therapy options.
November 16, 2020
Adamis plans to address agency concerns regarding the naloxone injection application.
November 11, 2020
There was a substantial increase in drug use-related endogenous endophthalmitis hospitalizations between 2003 and 2016.
November 04, 2020
A new study finds patients with sickle cell disease are moderately adherent to hydroxyurea.